{
  "schema_version": 1,
  "generated_at": "2026-09-23T17:36:11.872Z",
  "corpus_version": "v1-929074c7ba3b",
  "canonical_url": "https://marketinglaw.nimblevc.com/api/laws.json",
  "notice": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel.",
  "count": 5,
  "laws": [
    {
      "slug": "ca-prop65-supplement-warning",
      "url": "https://marketinglaw.nimblevc.com/law/ca-prop65-supplement-warning",
      "title": "California Prop 65 — Supplement Warning Advisory",
      "jurisdiction": "US-CA",
      "jurisdiction_label": "California",
      "jurisdiction_level": "state",
      "category_applicability": [
        "supplements"
      ],
      "channel_applicability": [
        "*"
      ],
      "effective_date": null,
      "enacted_date": null,
      "sunset_date": null,
      "severity": "note",
      "summary_plain": "California's Safe Drinking Water and Toxic Enforcement Act (Prop 65) requires\na warning when a product sold in California can expose consumers to a listed\nchemical. Some supplements — particularly herbals — can carry trace amounts\nof Prop-65-listed substances (e.g. heavy metals).\n\nWhat it means for you: this is an advisory note, not a content-blocking rule.\nWhen content references shipping to California, confirm whether the product\nneeds the standardized Prop 65 warning on its label / product page. This is a\nreference summary, not legal advice — confirm with counsel.\n",
      "citation": "CA Health & Safety Code §25249.6",
      "citation_url": null,
      "disclosure_text_suggested": null,
      "consult_counsel_framing": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel."
    },
    {
      "slug": "fda-drug-disease-claims",
      "url": "https://marketinglaw.nimblevc.com/law/fda-drug-disease-claims",
      "title": "FDA — Disease-Treatment & Drug-Classification Claims",
      "jurisdiction": "US",
      "jurisdiction_label": "United States (Federal)",
      "jurisdiction_level": "federal",
      "category_applicability": [
        "supplements"
      ],
      "channel_applicability": [
        "*"
      ],
      "effective_date": null,
      "enacted_date": null,
      "sunset_date": null,
      "severity": "block",
      "summary_plain": "Under the federal Food, Drug, and Cosmetic Act, a product that claims to\ntreat, cure, prevent, or diagnose a disease is legally classified as a\ndrug — which requires FDA approval. Dietary supplements are not drugs, so\nmarketing copy that makes disease-treatment claims, \"safe and effective\"\nclaims (FDA drug-approval language), or unqualified pediatric/pregnancy\nsafety claims puts the product at regulatory risk.\n\nWhat it means for you: keep supplement copy in structure-function territory\n(\"supports a calm mood\") rather than disease territory (\"treats anxiety\").\nThis is a reference summary, not legal advice — confirm with counsel.\n",
      "citation": "21 USC §321(g)(1)",
      "citation_url": null,
      "disclosure_text_suggested": null,
      "consult_counsel_framing": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel."
    },
    {
      "slug": "fda-dshea-structure-function",
      "url": "https://marketinglaw.nimblevc.com/law/fda-dshea-structure-function",
      "title": "FDA — DSHEA Structure-Function Claims & Disclaimer",
      "jurisdiction": "US",
      "jurisdiction_label": "United States (Federal)",
      "jurisdiction_level": "federal",
      "category_applicability": [
        "supplements"
      ],
      "channel_applicability": [
        "*"
      ],
      "effective_date": null,
      "enacted_date": null,
      "sunset_date": null,
      "severity": "warn",
      "summary_plain": "The Dietary Supplement Health and Education Act (DSHEA) permits supplements\nto make \"structure-function\" claims — describing how an ingredient affects\nthe body's structure or function (\"supports immune function\"). When a piece\nof content makes such a claim, the DSHEA disclaimer must appear in the same\ncontent piece.\n\nWhat it means for you: structure-function language is allowed, but pair it\nwith the DSHEA disclaimer. The flagging engine treats a structure-function\nclaim with no disclaimer present as a violation (companion-rule logic). This\nis a reference summary, not legal advice — confirm with counsel.\n",
      "citation": "21 USC §343(r)(6)",
      "citation_url": null,
      "disclosure_text_suggested": "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.",
      "consult_counsel_framing": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel."
    },
    {
      "slug": "ftc-255-endorsement-testimonial",
      "url": "https://marketinglaw.nimblevc.com/law/ftc-255-endorsement-testimonial",
      "title": "FTC — Endorsement & Testimonial Substantiation (§255 Guides)",
      "jurisdiction": "US",
      "jurisdiction_label": "United States (Federal)",
      "jurisdiction_level": "federal",
      "category_applicability": [
        "supplements"
      ],
      "channel_applicability": [
        "*"
      ],
      "effective_date": null,
      "enacted_date": null,
      "sunset_date": null,
      "severity": "warn",
      "summary_plain": "The FTC Endorsement & Testimonial Guides (16 CFR §255) require that\nadvertising claims based on customer testimonials be substantiated. Quantified\nresults (\"lost 20 lbs\"), time-bound results (\"in 30 days\"), and before/after\nframing all need a typical-results disclosure unless the advertiser can show\nthe result is what consumers generally achieve.\n\nWhat it means for you: when copy uses a testimonial-style result, pair it with\na \"results may vary\" / \"individual results may differ\" disclosure adjacent to\nthe claim. This is a reference summary, not legal advice — confirm with counsel.\n",
      "citation": "16 CFR §255",
      "citation_url": null,
      "disclosure_text_suggested": null,
      "consult_counsel_framing": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel."
    },
    {
      "slug": "ftc-5-deceptive-acts",
      "url": "https://marketinglaw.nimblevc.com/law/ftc-5-deceptive-acts",
      "title": "FTC — Deceptive Acts & Efficacy Substantiation (§5)",
      "jurisdiction": "US",
      "jurisdiction_label": "United States (Federal)",
      "jurisdiction_level": "federal",
      "category_applicability": [
        "supplements"
      ],
      "channel_applicability": [
        "*"
      ],
      "effective_date": null,
      "enacted_date": null,
      "sunset_date": null,
      "severity": "block",
      "summary_plain": "FTC §5 prohibits unfair or deceptive acts in advertising. For efficacy\nclaims this means an advertiser must hold \"competent and reliable scientific\nevidence\" before making the claim. \"Clinically proven\" / \"scientifically\nproven\" language and unsubstantiated efficacy superlatives (\"miracle\",\n\"guaranteed\", \"most effective\") are deceptive unless the advertiser can cite\nthe supporting evidence.\n\nWhat it means for you: either cite the study behind a proof claim or soften\nthe language to something substantiable (\"designed to support\", \"many\ncustomers report\"). This is a reference summary, not legal advice — confirm\nwith counsel.\n",
      "citation": "15 USC §45",
      "citation_url": null,
      "disclosure_text_suggested": null,
      "consult_counsel_framing": "Reference summary only — not legal advice. Confirm applicability and any required disclosure language with counsel."
    }
  ]
}